ABSTRACT. Manystudies on in vitro transformation of humancells indicate that the cells must be immortalized before they can be neoplastically transformed, indicating that immortalization is a critical step in multistep neoplastic transformation of humancells. Weimmortalized three human cell lines by repeated treatment with either 60Co gammarays or a chemical carcinogen, 4-nitroquinoline 1-oxide, and found that all three immortalized cell lines have mutations in the tumor suppressor gene, p53. Direct sequencing of the reverse-transcribed mRNA and immunoprecipitation of p53 protein revealed that mutant p53 is selectively expressed in all the immortalized cell lines, whereas the genomic fragments of the immortalized cells contain wild-type and mutated p53 alleles. Although the mutated p53 is selectively expressed in the immortalized cells, expression of the wild-type p53 was induced by treatment of the cells with a hypomethylating reagent, 5-azacytidine, indicating that the wild-type p53 allele might be inactivated by hypermethylation of DNA. Actually, the entire genomic locus including the promoter region of p53 is hypermethylated in all the immortalized cell lines. Expression and phosphorylation of Rb was normal in these three cell lines. Thus, inactivation of both wild type p53 alleles and selective expression of mutated p53 seem to be key factors in the immortalization of human nbroblasts.
Experimental models of in vitro malignant transformation of humancells provide considerable insight into the mechanisms of multistep carcinogenesis of human cells. Normal human cells must be immortalized before they can be neoplastically transformed. However, normal human cells are extremely refractory to immortalization, making in vitro neoplastic transformation of normal human cells very difficult (29) . Once these cells have been immortalized, they are transformed into malignant cells fairly easily with a variety of carcinogenic agents, such as oncogenes, chemical carcinogens, and ionizing radiation (4, 27, 28, 31, 32, 35, 37) . More than 50% of the human malignancies of epithelial, mesenchymal, hematopoietic, lymphoid, and neural origin analyzed so far, have been found to contain a mutated p53 gene (14, 21, 30) . Therefore, inactivation of the p53 tumor suppressor gene is currently regarded as an almost universal step in the developmant of human cancers. Although the role of p53 in multistep carcinogenesis of humancells remains unclear, manylines of evidence indicate that the loss of normal p53 function is associated with a disturbance of cell proliferation and/or with instability of the gene (17, 18, 20) .
Inactivation of the p53 gene has been observed as a late event in colorectal tumorigenesis (3), but participation of p53 in immortalization of cells has also been re- ported (25, 36) . Fibroblasts from patients with LiFraumeni syndrome have a mutation in a single allele of p53 (22, 33) , but are phenotypically normal and have a limited life span. Immortalization of Li-Fraumeni fibroblasts has been correlated with loss of the remaining wild-type allele (38) . These results suggest that inactivation of both p53 alleles may play an important role in immortalization of humancells.
The other tumor suppressor gene, Rb, has been reported to be involved in cellular aging (34) . The addition of Rb antisense oligomers to human diploid fibroblast cultures delayed their senescence, and co-addition of p53 and Rb antisense oligomers showed a greater senescence-delaying effect than the addition of antisense Rb alone (13). Although human diploid fibroblasts are extremely resistant to immortalization, we previously succeeded in immortalizing three human fibroblast cell lines, KMST-6, SUSM-1 and OUMS-24F, by treatment with either 60Co gammarays or a chemical carcinogen, 4-nitroquinoline 1-oxide (4NQO) (1, 26, 29 showedneither tumorigenicity on transplantation into nude mice nor anchorage-independent growth in soft agar, but they became tumorigenic upon the introduction of an activated ras gene (29) . These findings indicate that our established immortalized cell lines are valuable for studying the early stage of carcinogenesis of human cells. In the present study, we investigated the roles of p53 and Rb in the immortalization of human cells.
MATERIALS AND METHODS
Cells. Three normal human embryo fibroblast cell strains, HSF-412, KMS-6 and OUMS-24and their immortalized counterparts (SUSM-1, KMST-6 and OUMS-24F) were used in the present experiments. SUSM-1and OUMS-24Fcells were immortalized with 4NQO, and KMST-6was immortalized with 60Co gammarays. The details of the immortalization process are described elsewhere (1, 26, 29) . 5-Azacytidine treatment. 5-Azacytidine (Sigma, St. Louis, MO)was added to cultures at 4^M for OUMS-24Fand 8^M for SUSM-1and KMST-6.The cells were harvested after 9 days of treatment which included three changes of medium containing 5-azacytidine. quenced using an AmpliTaq cycle sequencing kit (Perkin-Elmer Cetus, Branchburg, NJ). To obtain specific PCRamplification from genomic DNAor mRNA, intron sequences for genomic DNAor exon-intron junction sequences for RTPCRwere used to produce PCRprimer sets. Immunoprecipitation. Randomlyproliferating cells or 5-azacytidine-treated cells were harvested, and proteins were extracted with 400 [A of lysis buffer [0.2% Nonidet P-40, 20 mM Tris-HCl (pH 8.0), 150 mMNaCl, 10 mM2-mercaptoethanol, 2 /ig/ml aprotinine, 2 /ig/ml pepstatin, 2^g/ml leupeptin and 100 /ig/ml phenylmethylsulfonyl fluoride]. Cell lysates were clarified by centrifugation at 12,000xg for 10 min at 4°C. Mousemonoclonal IgG against both the wild-type p53 (clone 1620, Oncogene Science, Inc., Manhasset, NY) (7) and the mutated p53 (clone 240, Oncogene Science) (ll), was immobilized on Afn-Gel Hz hydrazide gel (Bio-Rad, Hercules, CA) which covalently couples the Fc region of IgG. Cell lysates were gently mixed with the gel beads. Proteins were denatured and fractionated using SDS polyacrylamide (10%) gel electrophoresis, and transferred to a nitrocellulose membrane filter (Amersham). The filter was first blocked for 1 hour with TBST (20mM Tris-HCl, pH7.2, 100mM NaCl, 0.1%
Tween-20) containing 5% dry milk, incubated for 1.5 hr with a 1:100 dilution of p53 antibody (clone 1801, Oncogene Science, Inc.), which recognizes both mutant and wild-type p53, and finally washed four times. The filter was then incubated for 1 hr with a secondary antibody (1:1,000 dilution of horseradish peroxidase-conjugated sheep anti-mouse IgG, MBL, Nagoya, Japan), and p53 was detected using an enhanced chemiluminescence system (ECL, Amersham). Rbprotein was detected in the same wayusing rabbit IgG (against synthetic peptide P5) for immunoprecipitation, 6% polyacrylamide gel for electrophoresis, and rabbit IgG (against synthetic peptide P3) to detect blotted Rb protein (23) .
RESULTS
Detection of p53 mutations in immortal cells. SUSM-1cells, immortalized with 4NQO, had a mutation in exon 5 at codon 179, where CAT(histidine) was changed to AAT(asparagine). KMST-6cells immortalized with 60Co gammarays had a mutation in the same amino acid codon, resulting in the replacement of CAT(histidine) by CCT (proline). The other cell line, OUMS-24F, which was immortalized with 4NQO, had a mutation in exon 7 at codon 248, with a change from CGG (arginine) to CAG (glutamine). There were no other mutations within exons 4 to 9 in these three cell lines.
Although we treated the normal OUMS-24cells 59 times with 10~6 M4NQOto immortalize them, p53 remained normal at the 49th PD level in the cells that were treated 49 times with 4NQO (data not shown). However, just after these cells were immortalized by 4NQO(at the 69th PD level), only the mutated p53 was detected by RT-PCRsequence analysis. This result indicates that the mutated p53 was expressed immediately after immortalization of the cells and that the mutation of the p53 was not due to extensive passage of the immortalized cells.
Selective expression of the mutant p53. Only the mutant p53 was expressed in all three immortalized cell lines. This was shown by sequencing the expressed p53 mRNA (Fig. 1, A and C) , and by the fact that transcription of the normal alleles of p53 was completely inhibited. However, the sequencing analyses showed that the genomic fragments of the immortalized cells contained both wild-type and mutated p53 alleles (Fig. 1, B pressed only the mutant p53 (Fig. 2, lanes 3, 5 and 7) .
The amount of cell lysates used in the wild-type p53 lanes was 5 times more than that in the mutated p53 lanes, but the expression of the wild-type p53 in the im- Fig. 2 . Immunoprecipitation (IP) of p53 using wild-type (W)-and mutant (M)-specific monoclonal antibodies. Cell extracts used for detecting the wild-type p53 were 5-fold more concentrated than for the mutant p53. Immunoprecipitated proteins were eluted with SDSsample buffer, fractionated on SDS-polyacrylamide gel (10%), and transferred to a nitrocellulose membrane. A pantropic antibody, clone PAb1801, was used as the primary antibody for Western blotting. p53 proteins were precipitated with the monoclonal antibodies immobilized on hydrazide beads, but trace amounts of IgG were seen by chemiluminescent autoradiography. alleles caused selective expression of the mutated p53, but no genetic changes in the other wild-type allele were found in the three immortalized cell lines using Southern blotting and RT-PCRsequencing (data not shown).
We considered the possibility that hypermethylation might be involved in down-regulation of the wild-type p53. To test this hypothesis, we treated the immortalized cells with a deoxycytidine analog, 5-azacytidine, which inhibits methylation at cytosine sites in DNA. The RT-PCR products from 5-azacytidine-treated SUSM-1 and KMST-6 cells contained both wild-type and mutated p53 sequences (Fig. 3) , but the RT-PCR products from OUMS-24F treated with this same reagent, contained only mutant p53.
To further demonstrate induction of the wild-type p53 in the immortalized cell lines, we used the wild- case, all three immortalized cell lines expressed the wildtype p53 following treatment with 5-azacytidine (Fig. 2, lanes 9-1 1). Thus, although the wild-type p53 was undetectable in OUMS-24Fcells by RT-PCR sequence analysis, it became detectable by use of immunoprecipitation.
Rbprotein in three immortalized cell lines. Weanalyzed the expression of Rb protein in the three immortalized cell lines by immunoprecipitation and subsequent Western blotting. Since the HSF-412cells were near cellular aging, phosphorylated Rb protein was hardly observed. However, expression and the phosphorylated state of Rb protein were normal in all three immortalized cell lines (Fig. 4) . However, we could not exclude the possibility of small deletion(s) and/or mutation(s) in the Rb protein in these cell lines.
DISCUSSION
Our sequencing analyses demonstrated that all three human cell lines immortalized with either 4NQO or 60Co gammarays had mutations of the p53 gene. These mutated points are associated with the T-antigen-binding domain ofp53 as well as the hot spots for p53 mutation (16). The same mutation points have also been observed in many other human cancers (14, 30).
Other researchers have postulated that the mutant p53 inhibits the antiproliferative activity of the wildtype p53 via oligomerization (9, 19, 24) . However, the universality of the dominant negative phenotype for all p53 mutations is questionable owing to the high frequency of loss of heterozygosity at the p53 locus in manyhumantumors, resulting in the retention of only the mutant p53 allele (2, 3, 30) . A study on transcription and cell growth regulation using bicistronic vectors, which equally transcribed the wild-type and the mutant p53, indicated that the mutant protein could not completely suppress wild-type functions (10). Although the precise mechanismof selective expression of the mutated p53 in the three immortalized cell lines remainsunknown, selective expression seemsto be essential for the immortalization of humanfibroblasts. If hypermethylation is one of the mechanisms for inactivation of the p53 gene, then only one mutation or deletion appears to be sufficient for inactivation of p53 function when the other p53 allele has been inactivated by hypermethylation. If the wild-type p53 can be inactivated by hypermethylation in tumors, then, perhaps, treatment with chemotherapeutic agents that inhibit DNAmethylation will be effective for suppression of tumorgrowth.
Rb, which functions in the cell cycle, is regulated by phosphorylation (5, 6, 8, 23) . Using the immunoprecipitation method we detected no abnormalities in Rb in the three immortalized cell lines. Furthermore, among cell cycle regulatory genes, oncogenes and tumor suppressor genes, the only common genetic change that we have observed in the three immortalized cell lines is inactivation of p53 (15), although our three immortalized cell lines are obtained from the genetically independent individuals. Thus, inactivation of both wild type alleles of p53 and selective expression of mutated p53 seem to be one of key factors in the immortalization of human fibroblasts, though in addition to inactivation of p53, some other genetic changes maybe necessary for the immortalization of humancells.
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